Medical Systems - Adv Dev
Abstract
This Program Element (PE) funds development of medical materiel within the early system integration portion of the System Development and Demonstration phase of the acquisition life cycle using 6.4 (Advanced Component Development and Prototype) funding. Program efforts support transition of promising Science and Technology candidate medical technologies (drugs, vaccines, medical devices, diagnostics, and mechanisms for detection and control of disease carrying insects) to larger scale testing in humans for safety and effectiveness. Programs are aligned to meet future force requirements identified within concept documents and organizational structures. This PE also provides funding for Food and Drug Administration (FDA) regulated human clinical trials to gain additional information about safety and effectiveness on the path to licensure for use in humans. These efforts are managed by U.S. Army Medical Materiel Development Activity (USAMMDA) of the U.S. Army Medical Research and Development Command.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2025
- Source ID
- 0603807A_4_2040_PB_2025
- Change Summary Explanation
- Decrease due to alignment of medical health applications to DHA.
- Service Agency Name
- Army
Entities
Organizations
- United States Army
Related Documents
- Child Project: DoD Drug & Vacc Ad
- Child Accomplishment: DoD Drug and Vaccine Advanced Development - Medical Readiness
- Child Cost Item: 006e4a45068d230843e57e11a34cd7af
- Child Project: Field Medical Systems Advanced Development
- Child Accomplishment: Field Medical Systems Advanced Development - Medical Readiness
- Child Cost Item: 249dba41c6843ce7cdb8cfbe701acbab
- Child Cost Item: 098a38623c9b7cd530d57f57cec73603
- Child Cost Item: 8e3bfe4aabe4d6bc495e551bac4cd855
- Child Cost Item: 302a8bc8925c1d74ee29aaf0294aacb0